Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03733990
Title A Study to Evaluate Safety, Tolerability and Preliminary Efficacy of FP-1305 in Cancer Patients (MATINS)
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Faron Pharmaceuticals Ltd
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | GBR | FRA | FIN | ESP

Facility Status City State Zip Country Details
The University of Texas Health Science Center at San Antonio San Antonio Texas 78229-3901 United States Details
Clinical Research Institute HUCH Ltd Helsinki 00290 Finland Details
Oulu University Hospital Oulu 90220 Finland Details
Tampere University Hospital Tampere 33520 Finland Details
Turku University Hospital Turku 20520 Finland Details
The Institut Gustave Roussy Villejuif 94805 France Details
Erasmus University Medical Center Rotterdam Rotterdam 3015 GD Netherlands Details
START Madrid - CIOCC Hospital HM Sanchinarro Madrid 28050 Spain Details
The Royal Marsden NHS Foundation Trust Sutton Surrey SM2 5PT United Kingdom Details
Queen Elizabeth Hospital Birmingham Birmingham B15 2GW United Kingdom Details
The Christie NHS Foundation Trust Manchester M20 4BX United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field